3B Blackbio Dx Limited

BSE:532067 Stock Report

Market Cap: ₹12.1b

3B Blackbio Dx Past Earnings Performance

Past criteria checks 4/6

3B Blackbio Dx's earnings have been declining at an average annual rate of -1.5%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been declining at an average rate of 0.3% per year. 3B Blackbio Dx's return on equity is 16.1%, and it has net margins of 39.5%.

Key information

-1.5%

Earnings growth rate

-3.9%

EPS growth rate

Chemicals Industry Growth17.7%
Revenue growth rate-0.3%
Return on equity16.1%
Net Margin39.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How 3B Blackbio Dx makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:532067 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24925366670
31 Mar 24866321710
31 Dec 23787317680
30 Sep 23760281660
30 Jun 23734249550
31 Mar 23691259540
31 Dec 22701263450
30 Sep 22684253410
30 Jun 22663191380
31 Mar 22875322380
31 Dec 21873443360
30 Sep 211,157580340
30 Jun 212,109891410
31 Mar 212,2961,139470
31 Dec 202,173965420
30 Sep 201,799786430
30 Jun 20778294360
31 Mar 2030577290
31 Dec 1928862290
30 Sep 1927462270
30 Jun 1925554260
31 Mar 1924052260
31 Dec 1823445240
30 Sep 1823538230
30 Jun 1823435220
31 Mar 1823534210
31 Dec 1721229220
30 Sep 1719724210
30 Jun 1718018210
31 Mar 1716411200
31 Dec 161789200
30 Sep 161789200
30 Jun 161735200
31 Mar 161743200
31 Dec 151932332
30 Sep 151803332
30 Jun 151893200
31 Mar 151902190
31 Dec 141601392
30 Sep 141810372
30 Jun 142070200
31 Mar 142204342
31 Dec 132123322

Quality Earnings: 532067 has high quality earnings.

Growing Profit Margin: 532067's current net profit margins (39.5%) are higher than last year (34%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 532067's earnings have declined by 1.5% per year over the past 5 years.

Accelerating Growth: 532067's earnings growth over the past year (46.8%) exceeds its 5-year average (-1.5% per year).

Earnings vs Industry: 532067 earnings growth over the past year (46.8%) exceeded the Chemicals industry 9.4%.


Return on Equity

High ROE: 532067's Return on Equity (16.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies